Invivyd (IVVD)
0.82
-0.01 (1.20%)
Upcoming Events
Latest Headlines
Invivyd to Participate in Upcoming September Investor Conferences
September 8, 2026 7:01 AM - StreetInsider
Invivyd names chairman Marc Elia as CEO ahead of VYD2311 data
September 1, 2026 7:02 AM - StreetInsider
Invivyd Appoints Chairman Marc W. Elia as Chief Executive Officer; Approaches Results of VYD2311 studies DECLARATION and LIBERTY
September 1, 2026 7:01 AM - StreetInsider
Invivyd Inc. (IVVD) Reiterated at Overweight by Cantor Fitzgerald
August 27, 2026 7:27 AM - StreetInsider
Form 4 Invivyd, Inc. For: Aug 15 Filed by: Duke William E.
August 18, 2026 8:10 PM - SEC Filing
Form 4 Invivyd, Inc. For: Aug 15 Filed by: Green Julie
August 18, 2026 8:10 PM - SEC Filing
Form 4 Invivyd, Inc. For: Aug 15 Filed by: Lee Timothy Edward
August 18, 2026 8:10 PM - SEC Filing
Form 4 Invivyd, Inc. For: Aug 15 Filed by: Andersen Jill
August 18, 2026 8:10 PM - SEC Filing
Form 4 Invivyd, Inc. For: Aug 15 Filed by: Allen Robert D. III
August 18, 2026 8:10 PM - SEC Filing
H.C. Wainwright Reiterates Buy Rating on Invivyd Inc. (IVVD)
August 18, 2026 6:42 AM - StreetInsider
Form 144 Invivyd, Inc. Filed by: Green Julie
August 17, 2026 4:06 PM - SEC Filing
Form 144 Invivyd, Inc. Filed by: Lee Timothy Edward
August 17, 2026 4:06 PM - SEC Filing
Form 144 Invivyd, Inc. Filed by: Duke William E.
August 17, 2026 4:06 PM - SEC Filing
Form 144 Invivyd, Inc. Filed by: Andersen Jill
August 17, 2026 4:06 PM - SEC Filing
Form 144 Invivyd, Inc. Filed by: Allen Robert D. III
August 17, 2026 4:06 PM - SEC Filing
Form SCHEDULE 13G/A Invivyd, Inc. Filed by: PERCEPTIVE ADVISORS LLC
August 14, 2026 5:23 PM - SEC Filing
Form SCHEDULE 13G/A Invivyd, Inc. Filed by: BIOTECHNOLOGY VALUE FUND L P
August 14, 2026 4:18 PM - SEC Filing
Form 10-Q Invivyd, Inc. For: Jun 30
August 13, 2026 4:14 PM - SEC Filing
Form 8-K Invivyd, Inc. For: Aug 13
August 13, 2026 4:13 PM - SEC Filing
Invivyd Reports Second Quarter 2026 Financial Results and Recent Business Highlights
August 13, 2026 4:05 PM - StreetInsider
Form 4 Invivyd, Inc. For: Jul 31 Filed by: Mina Michael
August 4, 2026 4:15 PM - SEC Filing
Form 3 Invivyd, Inc. For: Jul 31 Filed by: Mina Michael
August 4, 2026 4:15 PM - SEC Filing
Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 4, 2026 7:01 AM - StreetInsider
Form SCHEDULE 13G Invivyd, Inc. Filed by: BlackRock, Inc.
July 28, 2026 4:45 PM - SEC Filing
Form 8-K Invivyd, Inc. For: Jul 23
July 24, 2026 4:05 PM - SEC Filing
H.C. Wainwright Reiterates Buy Rating on Invivyd Inc. (IVVD)
July 8, 2026 6:43 AM - StreetInsider
Form 8-K Invivyd, Inc. For: Jul 06
July 6, 2026 7:12 AM - SEC Filing
FDA notifies Invivyd that Pemgarda EUA will end June 2027
July 6, 2026 7:06 AM - StreetInsider
Invivyd Announces Receipt of Twelve Months’ Advanced Notice of Emergency Use Authorization (EUA) Termination for PEMGARDA® and Provides an Update on Next Steps with the U.S. FDA
July 6, 2026 7:01 AM - StreetInsider
Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 2, 2026 7:01 AM - StreetInsider
NovaBridge Biosciences Appoints Dr. Srishti Gupta as Chief Executive Officer
June 29, 2026 7:00 AM - Globe NewsWire
Full Article List
